NCT02449681 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02449681
Title	Study for Treatment of Patients With Recurrent or Metastatic SCCHN or SCCS
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Threshold Pharmaceuticals
Indications	skin squamous cell carcinoma laryngeal squamous cell carcinoma oropharynx cancer head and neck squamous cell carcinoma hypopharynx cancer oral cavity cancer
Therapies	TH-4000
Age Groups:	adult
Covered Countries	USA \| AUS

Filter rows:

Showing 1 to 10 of 10 entries

Facility	City	State	Zip	Country	Details
Chris O'Brien Lifehouse	Camperdown	New South Wales	2050	Australia	Details
Fox Chase Cancer Center	Philadelphia	Pennsylvania	19104	United States	Details
Georgetown Medical Center	Washington	District of Columbia	20007	United States	Details
Peter MacCallum	East Melbourne	Victoria	3002	Australia	Details
Stanford school of Medicine	Stanford	California	94305	United States	Details
University of Chicago	Chicago	Illinois	60637	United States	Details
University of Southern California-Norris	Los Angeles	California	90033	United States	Details
UT Southwestern Medical Center	Dallas	Texas	75390	United States	Details
Vanderbilt-Ingram Cancer Center (VICC)	Nashville	Tennessee	37232	United States	Details
Walter Reed National Military Cancer Center	Bethesda	Maryland	20889	United States	Details

Showing 1 to 10 of 10 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02449681Clinical Trial Detail